Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating β-Catenin Signaling
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incomplete Radiofrequency Ablation Enhances Invasiveness and Metastasis of Residual Cancer of Hepatocellular Carcinoma Cell HCCLM3 via Activating β-Catenin Signaling
Authors
Keywords
Hepatocellular carcinoma, Metastasis, Mouse models, Messenger RNA, Transcription factors, Vimentin, Cancer treatment, Immunofluorescence staining
Journal
PLoS One
Volume 9, Issue 12, Pages e115949
Publisher
Public Library of Science (PLoS)
Online
2014-12-27
DOI
10.1371/journal.pone.0115949
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation
- (2014) Hidetoshi Nakagawa et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- LIM protein JUB promotes epithelial-mesenchymal transition in colorectal cancer
- (2014) Xing-Hua Liang et al. CANCER SCIENCE
- Overexpression of SOX2 promotes migration, invasion, and epithelial-mesenchymal transition through the Wnt/β-catenin pathway in laryngeal cancer Hep-2 cells
- (2014) Ning Yang et al. TUMOR BIOLOGY
- Down-regulation of FoxM1 leads to the inhibition of the epithelial-mesenchymal transition in gastric cancer cells
- (2014) Lifeng Miao et al. Cancer Genetics
- Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma
- (2013) Shuhei Yoshida et al. HEPATOLOGY
- β-Catenin activation contributes to the pathogenesis of adenomyosis through epithelial-mesenchymal transition
- (2013) Seo Jin Oh et al. JOURNAL OF PATHOLOGY
- Sorafenib suppresses the rapid progress of hepatocellular carcinoma after insufficient radiofrequency ablation therapy: An experiment in vivo
- (2012) Ming Xu et al. ACTA RADIOLOGICA
- Incomplete thermal ablation stimulates proliferation of residual renal carcinoma cells in a translational murine model
- (2012) Stephanie G.C. Kroeze et al. BJU INTERNATIONAL
- MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis
- (2012) Keun Hur et al. GUT
- After insufficient radiofrequency ablation, tumor-associated endothelial cells exhibit enhanced angiogenesis and promote invasiveness of residual hepatocellular carcinoma
- (2012) Jian Kong et al. Journal of Translational Medicine
- Insufficient Radiofrequency Ablation Promotes Angiogenesis of Residual Hepatocellular Carcinoma via HIF-1α/VEGFA
- (2012) Jian Kong et al. PLoS One
- Radiofrequency Ablation for Hepatocellular Carcinoma: 10-Year Outcome and Prognostic Factors
- (2011) Shuichiro Shiina et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Knockdown of β-Catenin Through shRNA Cause a Reversal of EMT and Metastatic Phenotypes Induced by HIF-1α
- (2011) Jia-Hui Zhao et al. CANCER INVESTIGATION
- The Wnt/β-catenin pathway as a therapeutic target in human hepatocellular carcinoma
- (2011) Rajae Dahmani et al. Clinics and Research in Hepatology and Gastroenterology
- Activation of -Catenin by Hypoxia in Hepatocellular Carcinoma Contributes to Enhanced Metastatic Potential and Poor Prognosis
- (2010) L. Liu et al. CLINICAL CANCER RESEARCH
- Depletion of Tumor-Associated Macrophages Enhances the Effect of Sorafenib in Metastatic Liver Cancer Models by Antimetastatic and Antiangiogenic Effects
- (2010) W. Zhang et al. CLINICAL CANCER RESEARCH
- Epithelial-mesenchymal transition in the liver
- (2010) D. Firrincieli et al. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE
- Epidemiology and Management of Hepatocellular Carcinoma
- (2010) Ju Dong Yang et al. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
- Low temperature of radiofrequency ablation at the target sites can facilitate rapid progression of residual hepatic VX2 carcinoma
- (2010) Shan Ke et al. Journal of Translational Medicine
- E-cadherin, β-catenin, and ZEB1 in malignant progression of cancer
- (2009) Otto Schmalhofer et al. CANCER AND METASTASIS REVIEWS
- Hepatocellular carcinoma development induced by conditional β-catenin activation inLkb1+/−mice
- (2009) Hiroyuki Miyoshi et al. CANCER SCIENCE
- Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model: Relevance of epithelialâmesenchymal transition
- (2009) Liang Liu et al. CANCER SCIENCE
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
- (2009) Claudio Zavaglia et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Epithelial–mesenchymal transition in hepatocellular carcinoma
- (2009) Franziska van Zijl et al. Future Oncology
- Rho-kinase 2 is frequently overexpressed in hepatocellular carcinoma and involved in tumor invasion
- (2009) Carmen Chak-Lui Wong et al. HEPATOLOGY
- The basics of epithelial-mesenchymal transition
- (2009) Raghu Kalluri et al. JOURNAL OF CLINICAL INVESTIGATION
- The Current Role of Radiofrequency Ablation in the Management of Hepatocellular Carcinoma
- (2008) Wan Yee Lau et al. ANNALS OF SURGERY
- Biological characteristics of fluorescent protein-expressing human hepatocellular carcinoma xenograft model in nude mice
- (2008) Bi-Wei Yang et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Molecular targeted therapies in hepatocellular carcinoma
- (2008) Josep M. Llovet et al. HEPATOLOGY
- Snail and Slug Promote Epithelial-Mesenchymal Transition through β-Catenin–T-Cell Factor-4-dependent Expression of Transforming Growth Factor-β3
- (2008) Damian Medici et al. MOLECULAR BIOLOGY OF THE CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started